Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


24.07.2017

1 Epidemiol Infect
1 J Gen Virol
1 J Immunol
4 J Virol
2 PLoS One
2 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Epidemiol Infect

  1. MGBERE O, Ngo K, Khuwaja S, Mouzoon M, et al
    Pandemic-related health behavior: repeat episodes of influenza-like illness related to the 2009 H1N1 influenza pandemic.
    Epidemiol Infect. 2017 Jul 20:1-7. doi: 10.1017/S0950268817001467.
    PubMed     Text format     Abstract available


    J Gen Virol

  2. KANDEIL A, Kayed A, Moatasim Y, Webby RJ, et al
    Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt.
    J Gen Virol. 2017 Jul 18. doi: 10.1099/jgv.0.000847.
    PubMed     Text format     Abstract available


    J Immunol

  3. TULLY CM, Chinnakannan S, Mullarkey CE, Ulaszewska M, et al
    Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.
    J Immunol. 2017 Jul 19. pii: ji1600939. doi: 10.4049/jimmunol.1600939.
    PubMed     Text format     Abstract available


    J Virol

  4. WIEGAND MA, Gori-Savellini G, Gandolfo C, Papa G, et al
    Respiratory syncytial virus (RSV) vaccine vectored by a stable chimeric and replication-deficient Sendai virus protects mice without inducing enhanced disease.
    J Virol. 2017 Mar 1. pii: JVI.02298-16. doi: 10.1128/JVI.02298.
    PubMed     Text format     Abstract available

  5. ZHANG L, Li H, Hai Y, Yin W, et al
    CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in
    J Virol. 2017;91.
    PubMed     Text format     Abstract available

  6. BOYOGLU-BARNUM S, Todd SO, Meng J, Barnum TR, et al
    Mutating the CX3C motif in the G protein should make a live respiratory syncytial virus vaccine safer and more effective.
    J Virol. 2017 Mar 8. pii: JVI.02059-16. doi: 10.1128/JVI.02059.
    PubMed     Text format     Abstract available

  7. NTURIBI E, Bhagwat AR, Coburn S, Myerburg MM, et al
    Intracellular Colocalization of Influenza Viral RNA and Rab11A is Dependent upon Microtubule Filaments.
    J Virol. 2017 Jul 19. pii: JVI.01179-17. doi: 10.1128/JVI.01179.
    PubMed     Text format     Abstract available


    PLoS One

  8. TE BEEST DE, de Bruin E, Imholz S, Koopmans M, et al
    Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).
    PLoS One. 2017;12:e0181093.
    PubMed     Text format     Abstract available

  9. YU Z, Liu J, Wang X, Zhu X, et al
    Efficient Vaccine Distribution Based on a Hybrid Compartmental Model.
    PLoS One. 2016;11:e0155416.
    PubMed     Text format     Abstract available


    Vaccine

  10. MORCL T, Hurst BL, Tarbet EB
    Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.
    Vaccine. 2017 Jul 14. pii: S0264-410X(17)30912.
    PubMed     Text format     Abstract available

  11. MAKARKOV AI, Chierzi S, Pillet S, Murai KK, et al
    Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages.
    Vaccine. 2017 Jul 13. pii: S0264-410X(17)30908.
    PubMed     Text format     Abstract available


    Virology

  12. ALKHERAIF AA, Topliff CL, Reddy J, Massilamany C, et al
    Type 2 BVDV Npro suppresses IFN-1 pathway signaling in bovine cells and augments BRSV replication.
    Virology. 2017;507:123-134.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: